Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
hERG is best known as a primary anti-target, the inhibition of which is responsible for serious side effects. A renewed interest in hERG as a desired target, especially in oncology, was sparked because of its role in cellular proliferation and apoptosis. In this study, we survey the most recent advances regarding hERG by focusing on SAR in the attempt to elucidate, at a molecular level, off-target and on-target actions of potential hERG binders, which are highly promiscuous and largely varying in structure. Understanding the rationale behind hERG interactions and the molecular determinants of hERG activity is a real challenge and comprehension of this is of the utmost importance to prioritize compounds in early stages of drug discovery and to minimize cardiotoxicity attrition in preclinical and clinical studies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.drudis.2019.11.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring the Neuroprotective Potentials of Flavonoid Metabolites in : A Review with in-silico Insight to Therapeutic Potential.
J Exp Pharmacol
August 2025
Human Anatomy Department, Kampala International University, Bushenyi, Uganda.
The worldwide occurrence of neurodegenerative diseases in Alzheimer's and Parkinson's patients is increasing owing to multiple disease mechanisms, including oxidative stress, neuroinflammation, mitochondrial dysfunction, and excitotoxicity. (clove) flavonoid metabolites show strong neuroprotective potential because they act as antioxidants, reduce inflammation and lipid peroxidation, and prevent apoptosis. The key flavonoid metabolites, quercetin, kaempferol, kumatakenin, myricetin, ombuin 3-O-β-d-glucopyranoside, and tamarixetin 3-O-β-d-glucopyranoside, bind to various brain receptors implicated in disease propagation pathways and induce changes that support neuronal survival and decrease cognitive impairment.
View Article and Find Full Text PDFHuman sclerostin-inspired short peptides reverse osteoporosis and suppress joint degeneration in osteoarthritis via opposing Wnt pathways.
Biomed Pharmacother
September 2025
Division of Endocrinology and Centre for Research in ASTHI, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India. Electronic address:
Sclerostin, a key regulator of Wnt/β-catenin signaling, exhibits dual therapeutic potential in bone disorders: its inhibition promotes bone formation in osteoporosis, while its mimicry suppresses aberrant bone growth in osteoarthritis (OA). Using structural insights from NMR studies, we identified two sclerostin-derived peptides: SC-1 (an 18-mer) from loop 2, and SC-3 (a 14-mer) from loop 3. Molecular modeling showed that SC-1 binds to the first ectodomain of LRP6, potentially displacing sclerostin through competitive inhibition to activate Wnt signaling.
View Article and Find Full Text PDFSex-specific human electromechanical multiscale in-silico models for virtual therapy evaluation.
J Mol Cell Cardiol Plus
September 2025
Department of Computer Science, University of Oxford, Oxford, United Kingdom.
Background: Women are under-represented in cardiovascular research, leading to poorer outcomes. Investigating sex-differences in electromechanical function is essential for improving therapy evaluation. This study presents sex-specific human cellular and biventricular electromechanical models for mechanistic investigation of sex-differences in therapeutic response.
View Article and Find Full Text PDFBioisosterism-driven design of orally active, safe, and broad-spectrum biphenyl-DAPY derivatives as highly potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Acta Pharm Sin B
August 2025
Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
This study aimed to identify ideal pharmaceutical candidates featuring strong anti-HIV-1 activity and desirable drug-like characteristics. Our endeavor involved the implementation of a bioisosterism strategy, leading to the discovery of an assemblage of halogen-containing biphenyl-diarylpyrimidines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors. Notably, compound demonstrated exceptional efficacy against both WT HIV-1 (EC = 1.
View Article and Find Full Text PDFSynthesis and structural characterization of coumarin-hydrazone derivatives as antiplatelet agents: in vitro and in silico evaluation of activity and toxicity.
3 Biotech
September 2025
Laboratory of Molecular Biotechnology of Eucaryotes, Centre of Biotechnology of Sfax, University of Sfax, B.P 1177, 3018 Sfax, Tunisia.
Unlabelled: The aim of this work is the synthesis of nine coumarin-hydrazone derivatives and their characterization by IR, 1D NMR, 2D NMR, NOESY, and elemental analysis, as well as the evaluation of their antiplatelet activity through in vitro and in silico tests. Among the tested series, compounds and showed significant inhibition of ADP-induced platelet aggregation, by 87% and 98%, respectively. Notably, compound completely inhibited arachidonic acid-induced aggregation, while none of the molecules affected the collagen pathway.
View Article and Find Full Text PDF